new
enzymelink
immunosorb
assay
elisa
base
immunoglobulin
g
igg
plusigm
antibodi
detect
test
sever
acut
respiratori
syndrom
sar
develop
use
cocktail
four
recombin
polypeptid
antigen
recombin
fragment
design
part
two
differ
structur
protein
sarsassoci
coronaviru
sarscov
one
recombin
polypeptid
design
part
spike
glycoprotein
three
polypeptid
compris
almost
whole
nucleocapsid
protein
avoid
last
ctermin
amino
acid
immun
cocktail
four
polypeptid
yield
specif
polyclon
antibodi
abl
recogn
sarscovinfect
cell
immunofluoresc
assay
polypeptid
cocktail
also
use
set
elisabas
iggplusigm
antibodi
detect
test
show
specif
sensit
upon
evalu
use
sera
healthi
neg
control
sar
patient
separ
immunoreact
assay
recombin
polypeptid
demonstr
combin
n
protein
fragment
suitabl
individu
peptid
develop
serolog
assay
sarscov
new
coronaviru
cov
order
nidoviral
famili
coronavirida
genu
coronaviru
implic
causal
agent
sever
acut
respiratori
syndrom
sar
singlestrand
plussens
rna
genom
kb
contain
put
open
read
frame
includ
four
major
structur
protein
common
known
cov
spike
membran
envelop
e
nucleocapsid
n
protein
control
epidem
requir
rapid
accur
diagnost
techniqu
promptli
identifi
infect
allow
treatment
implement
infect
control
measur
includ
isol
case
manag
contact
prevent
transmiss
develop
sensit
highli
specif
diagnost
kit
effect
earli
stage
sar
great
interest
highli
contagi
acut
natur
diseas
ii
stress
caus
individu
unnecessari
quarantin
epidem
iii
absenc
effect
antisar
therapi
howev
level
viru
excret
compar
low
initi
phase
sar
therefor
earli
diagnosi
requir
highli
sensit
test
detect
low
level
viral
genom
viral
protein
present
first
day
sar
onset
sever
molecular
assay
design
provid
earli
diagnosi
base
detect
specif
rna
sequenc
pcr
howev
rna
extract
protocol
straightforward
may
produc
rna
prepar
use
revers
transcript
protocol
properli
follow
yield
falseposit
result
specif
antibodi
antigen
detect
test
would
technolog
simpler
less
expens
thu
object
present
studi
develop
easytous
diagnost
assay
evalu
use
combin
recombin
protein
obtain
sarsassoci
cov
sarscov
enzymelink
immunosorb
assay
elisa
base
antibodi
detect
test
publish
studi
drew
attent
n
protein
appear
ideal
target
earli
sensit
sarscov
diagnost
kit
protein
project
viral
surfac
major
neutral
antigen
known
cov
play
import
role
initi
stage
infect
form
characterist
corona
larg
distinct
spike
viral
envelop
n
protein
describ
krokhin
et
al
major
immunogen
sarscov
abund
protein
throughout
infect
previou
studi
suggest
combin
two
protein
assay
may
need
confirm
specif
presumpt
sar
antibodi
offer
sensit
serodiagnosi
reason
studi
focus
natur
immun
respons
sar
patient
recombin
sprotein
nprotein
cocktail
use
antigen
elisabas
antibodi
detect
test
bacteri
strain
viru
sera
bacteri
strain
use
studi
purchas
invitrogen
novagen
describ
previous
amplifi
gene
fragment
obtain
revers
transcriptionpcr
rtpcr
use
sampl
genom
rna
extract
cell
infect
sarscov
isol
viru
avail
research
commun
thank
h
w
doerr
colleagu
univers
frankfurt
frankfurt
germani
rna
sampl
prepar
robertkoch
institut
berlin
germani
kindli
provid
matthia
niedrig
also
suppli
posit
sera
sar
patient
perform
elisa
addit
sarscovposit
sera
use
mixtur
four
recombin
polypeptid
describ
studi
neg
control
consist
serum
sampl
healthi
popul
saragossa
area
expos
sar
serum
sampl
individu
infecti
diseas
dna
manipul
coval
close
circular
dna
purifi
sodium
dodecyl
sulfat
sd
lysi
method
follow
phenol
extract
ethanol
precipit
analyt
gel
electrophores
plasmid
restrict
fragment
carri
wtvol
agarosetrisborateedtaethidium
bromid
horizont
slab
gel
dna
concentr
determin
use
molar
extinct
coeffici
cm
nm
gener
dna
manipul
method
report
previous
doublestrand
dna
sequenc
reaction
perform
neyra
institut
parasitolog
biomedicin
granada
spain
amplif
gene
insert
lyophil
rna
solubil
l
steril
deioniz
rnasefre
water
treat
diethyl
pyrocarbon
appar
concentr
genom
unitsml
appropri
oligonucleotid
synthes
analyt
servic
depart
dna
technolog
correspond
sequenc
posit
shown
tabl
rtpcr
condit
amplif
recommend
collabor
multicentr
research
project
sever
acut
respiratori
syndrom
diagnosi
http
wwwwhointcsrsarsprojecten
reaction
mixtur
contain
l
rna
pmol
two
oligonucleotid
primer
deoxynucleosid
triphosph
buffer
superscript
iii
rtplatinum
taq
enzym
mix
supplement
mm
mg
reaction
initi
u
superscript
iii
rtplatinum
taq
enzym
mix
invitrogen
express
escherichia
coli
sequenc
amplifi
appropri
oligonucleotid
primer
clone
novagen
andor
prset
invitrogen
express
vector
plasmid
subsequ
use
transform
e
coli
express
host
rosetta
plyss
express
system
protein
purif
truncat
histag
fusion
protein
term
purifi
extract
rosetta
cell
bacteri
clone
transform
correspond
plasmid
grown
luriabertani
medium
contain
gml
ampicillin
reach
mm
iptg
ad
cultur
grown
addit
h
cell
harvest
centrifug
g
pellet
use
immedi
frozen
scaleup
purif
procedur
frozen
pellet
liter
rosetta
cell
overproduc
thaw
resuspend
denatur
lysi
buffer
mm
trishcl
ph
mm
sodium
phosphat
urea
emulphogen
polyoxyethylen
ether
sigma
mm
imidazol
mm
phenylmethylsulfonyl
fluorid
contain
nacl
equilibr
ph
n
naoh
cell
lyse
sonic
crude
extract
centrifug
g
min
supernat
purifi
use
nickelnitrilotriacet
acidagaros
matrix
column
accord
manufactur
instruct
qiagen
protein
manipul
appar
molecular
mass
polypeptid
determin
sdspolyacrylamid
gel
electrophoresi
page
concentr
protein
determin
uv
absorb
nm
use
molar
extinct
coeffici
calcul
describ
gill
von
hippel
polyclon
antibodi
sarscov
polyclon
antibodi
prepar
immun
rabbit
intramuscular
inject
g
protein
g
recombin
polypeptid
ml
emuls
contain
freund
complet
adjuv
dose
repeat
day
dose
prepar
incomplet
adjuv
inject
day
second
dose
serum
use
correspond
blood
sampl
drawn
month
third
inject
ifa
immunofluoresc
assay
ifa
use
sarscovinfect
cell
commerci
sarscov
ifa
kit
euroimmun
briefli
rabbit
polyclon
serum
obtain
first
purifi
protein
affin
chromatographi
hitrap
protein
hp
amersham
biolab
label
fluorescein
isothiocyan
sigma
dilut
fluoresceinlabel
rabbit
polyclon
antibodi
incub
min
sarscovinfect
cell
noninfect
cell
use
control
wash
reaction
visual
fluoresc
microscopi
elisa
measur
microtit
plate
coat
mixtur
four
recombin
polypeptid
dilut
phosphatebuff
salin
pb
concentr
gml
gml
gml
gml
gml
incub
overnight
room
temperatur
plate
block
newborn
calf
serum
wash
incub
sera
sar
patient
healthi
control
pb
contain
newborn
calf
serum
min
wash
dilut
peroxidaseconjug
goat
antihuman
immunoglobulin
g
igg
plu
igm
jackson
ad
incub
min
final
peroxidas
reaction
visual
use
tetramethylbenzidinehydrogen
peroxid
solut
substrat
neogen
corpor
elisa
singl
recombin
protein
appli
plate
also
perform
six
sar
serum
sampl
antigen
dilut
use
protocol
describ
follow
western
blot
briefli
g
purifi
polypeptid
load
onto
sdspage
gel
transfer
nitrocellulos
membran
use
biorad
mini
transblot
transfer
unit
membran
first
block
pb
contain
tween
nonfat
dri
milk
room
temperatur
h
incub
specif
primari
antibodi
dilut
wash
buffer
pb
tween
membran
wash
five
time
incub
horseradish
peroxidaselabel
antirabbit
igg
sigma
protein
visual
peroxidas
reaction
use
tetramethylbenzidinehydrogen
peroxid
solut
substrat
calcul
cdna
synthes
rtpcr
clone
express
vector
four
differ
polypeptid
prepar
three
correspond
nucleocapsid
protein
viru
fourth
correspond
spike
protein
amplifi
fragment
first
clone
prset
sever
problem
relat
overexpress
heterolog
gene
appear
therefor
three
fragment
clone
system
express
vector
increas
product
much
lysat
induc
cell
display
heterolog
protein
present
noninduc
cell
data
shown
densitometr
scan
stain
gel
show
level
induc
protein
approxim
respect
level
solubl
protein
e
coli
contain
express
construct
high
protein
yield
obtain
treat
bacteri
pellet
buffer
contain
urea
follow
strong
probe
sonic
briefli
clarifi
extract
e
coli
rosetta
fig
peptid
show
similar
antigen
immun
rabbit
western
blot
analysi
polyclon
serum
rabbit
immun
mixtur
four
recombin
polypeptid
show
recombin
fragment
react
antibodi
similar
manner
fig
polyclon
antibodi
also
subject
separ
elisa
recombin
polypeptid
result
obtain
consist
western
blot
show
slightli
greater
antigen
capac
n
protein
fragment
order
highest
lowest
antigen
data
shown
sever
pathogen
antigen
also
test
rabbit
polyclon
serum
chlamydophila
pneumonia
mycoplasma
pneumonia
coxiella
burnetii
cytomegaloviru
adenoviru
influenza
viru
influenza
b
viru
respiratori
syncyti
viru
herpesviru
crossreact
detect
data
shown
polyclon
antibodi
induc
polypeptid
mixtur
show
high
reactiv
sarscovinfect
cell
rabbit
polyclon
serum
incub
sarscovinfect
noninfect
cell
visual
immunofluoresc
figur
show
cell
infect
viru
intact
nuclear
membran
fluoresc
signal
locat
cytoplasm
immunofluoresc
observ
noninfect
cell
recombinantproteinbas
elisa
antibodi
detect
mixtur
four
recombin
polypeptid
use
coat
antigen
develop
elisabas
iggplusigm
test
detect
sand
nspecif
antibodi
sarscov
assay
specif
studi
use
serum
sampl
healthi
ifavalid
control
dilut
select
cutoff
valu
give
specif
dilut
sera
sar
patient
clinic
diagnos
ifa
valid
studi
use
sand
nbase
elisa
sampl
cutoff
valu
give
sensit
fig
specif
assay
also
test
use
sera
individu
infect
nonsarsrel
respiratori
virus
adenoviru
respiratori
syncyti
viru
influenza
viru
influenza
b
viru
parainfluenza
viru
antinuclear
antibodi
rheumatoid
factor
sera
also
valid
ifa
negativecontrol
sampl
sarscov
crossreact
detect
sinc
none
serum
sampl
posit
tabl
control
serum
sampl
n
data
shown
sar
patient
serum
sampl
could
test
use
tabl
regard
individu
sensit
immunogen
n
polypeptid
immunogen
equal
respect
specif
recombin
fragment
respons
falseposit
result
obtain
four
recombin
polypeptid
correspond
two
differ
structur
protein
evalu
use
sarscov
diagnost
kit
studi
fragment
spike
glycoprotein
amino
acid
select
mean
bioinformat
analysi
fragment
overlap
sever
region
report
contain
linear
epitop
thu
lu
et
al
identifi
c
domain
bp
major
immunodomin
domain
protein
zhou
et
al
found
sprotein
residu
elicit
neutral
antibodi
viru
cocktail
recombin
antigen
use
produc
polyclon
antibodi
order
test
capac
trigger
immun
reaction
recogn
nativ
antigen
demonstr
antibodi
abl
detect
sarscov
immunofluoresc
infect
cell
show
function
antigen
recombin
polypeptid
similar
nativ
counterpart
recombin
polypeptid
use
develop
elisabas
iggplusigm
antibodi
detect
test
sera
clinic
diagnos
sar
patient
avail
studi
assay
perform
combin
four
recombin
polypeptid
use
sera
healthi
donor
exposur
sarscov
control
show
sensit
specif
one
possibl
explan
two
falseneg
result
may
essenti
linear
antigen
site
locat
outsid
select
spike
protein
fragment
sinc
polypeptid
cover
less
onethird
protein
sequenc
furthermor
immunogen
recombin
protein
sarscov
may
lower
nativ
counterpart
due
effect
express
system
use
overproduc
recombin
polypeptid
possibl
loss
essenti
conformationandor
glycosylationdepend
epitop
n
protein
report
free
glycosyl
site
appear
chang
immunolog
characterist
even
express
prokaryot
system
nevertheless
heavi
glycosyl
spike
protein
mannos
andor
hybrid
oligosaccharid
may
make
suitabl
candid
use
eukaryot
rather
bacteri
system
howev
separ
analysi
polypeptid
six
sarscovposit
serum
sampl
show
fragment
reactiv
three
six
sera
less
immunogen
nucleocapsid
protein
reactiv
five
six
sera
due
addit
result
three
fragment
howev
spike
protein
fragment
react
one
serum
sampl
sampl
react
n
antigen
similar
find
publish
woo
et
al
yu
et
al
conclud
recombin
nbase
igg
elisa
sensit
recombin
sbase
igg
elisa
serodiagnosi
sarscov
elisa
polypeptid
obtain
nucleocapsid
protein
show
immunogen
region
taken
account
studi
use
six
posit
serum
sampl
therefor
result
confirm
repres
number
sarscovposit
sera
result
cutoff
respect
b
neg
control
compris
serum
sampl
healthi
blood
donor
gave
falseposit
result
sarscovneg
sera
individu
infect
nonsarsrel
respiratori
virus
antinuclear
antibodi
rheumatoid
factor
use
crossreact
experi
c
data
correspond
analys
individu
recombin
polypeptid
combin
six
sarscovposit
serum
sampl
fragment
spike
protein
direct
serolog
perform
human
cov
strain
crossreact
assay
larg
percentag
serum
sampl
neg
control
probabl
contain
antibodi
highli
preval
virus
thu
human
cov
report
respons
around
common
cold
fact
may
explain
falseposit
result
obtain
sinc
crossreact
polypeptid
identifi
may
attribut
highli
conserv
motif
describ
vlasova
et
al
present
n
protein
cov
although
one
falseposit
serum
specimen
obtain
unexpos
individu
potenti
crossreact
sarscov
human
cov
directli
assess
studi
remain
concern
analysi
elisa
show
recombin
polypeptid
differ
level
immunogen
sarscovposit
sera
one
specif
mixtur
four
recombin
protein
demonstr
higher
sensit
specif
detect
antibodi
sera
patient
henc
report
new
elisabas
iggplusigm
antibodi
detect
test
diagnosi
sar
due
high
degre
pathogen
infect
sarscov
human
detect
igm
igg
antibodi
may
method
choic
serodiagnosi
increas
sensit
specif
assay
use
cocktail
sarscov
n
protein
furthermor
use
protein
fragment
polypeptid
instead
whole
recombin
protein
antibodi
detect
may
part
resolv
issu
potenti
crossreact
protein
human
cov
